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Introduction: Coagulase-negative staphylococci (CoNS) are the main pathogens responsible 
for prosthetic joint infections (PJIs). As normal inhabitants of human skin, it is often difficult to 
define if they are contaminants, or if they have an active role in initiating infection. This study 
aims to evaluate differences in CoNS organisms (Staphylococcus hominis, Staphylococcus 
capitis, Staphylococcus haemolyticus, Staphylococcus warneri) and Staphylococcus aureus in 
terms of isolation rate and antimicrobial susceptibility from patients who met the International 
Consensus Meeting (ICM) criteria for PJIs and those who did not. 
Methods: Staphylococci isolates from January 2014 to December 2015 retrieved from patients 
undergoing revision joint arthroplasty were classified in accordance with criteria established 
by the ICM of Philadelphia. 
Results: As per the consensus classification, 50 CoNS and 39 S. aureus infections were rec-
ognized as pathogens, while 16 CoNS and four S. aureus were considered as contaminants. 
Frequency of isolation of S. aureus was significantly higher in infected patients than in those 
without infection, while no significant differences were observed among CoNS. Resistance to 
levofloxacin, erythromycin, gentamicin trimethoprim/sulfamethoxazole, and rifampicin was 
significantly more frequent in S. haemolyticus than in the other species, as well as resistance to 
erythromycin and gentamicin in S. hominis. In comparison to S. aureus, CoNS were significantly 
more resistant to daptomycin and gentamicin and more susceptible to rifampicin.
Conclusion: CoNS, other than Staphylococcus epidermidis, are frequently isolated from PJIs, 
and their infective role and antimicrobial susceptibility need to be assessed on an individual 
patient basis. S. haemolyticus seems to emerge as responsible for PJI in a large volume of 
patients, and its role needs to be further investigated, also considering its pattern of resistance. 
Keywords: periprosthetic joint infections, antibiotics susceptibility, Staphylococcus haemolyticus, 
Staphylococcus hominis, Staphylococcus capitis, Staphylococcus warneri, Staphylococcus aureus
Introduction
Management of established prosthetic joint infection (PJI) requires a combination 
of pathogen-specific antibiotics and surgical intervention. The choice of antibiotic is 
dependent upon the microbiological cultures of specimens obtained preoperatively or 
intraoperatively, with a greater sensitivity and specificity seen associated with tissue 
samples, compared to aspirations or swabs.1,2
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Due to the lack of laboratory assays with high sensitivity 
and specificity for PJI diagnosis, a multidisciplinary approach 
that combines results from microbiological, biochemical, 
and histological analyses, with clinical and radiological 
examination should be adopted. Therefore, several criteria 
for diagnosing PJI have been proposed by various scientific 
and medical societies.3–6 Despite some differences, they 
all highlight the role of tissue culture and the need to dis-
criminate between pathogens and contaminants, enabling 
antimicrobial susceptibility testing to target the causative 
agent, thus improving patient outcome. 
Staphylococcus aureus and Staphylococcus epidermidis 
are the predominant pathogens responsible for PJI.9,10 They 
are part of the natural skin microbiota, but can lead to dev-
astating consequences should they establish themselves on 
the surface of an implant, produce biofilm, and evade host-
immune defense.11 
Improvement of methods for microbial identification 
has led to an increased rate of isolation of microorganisms, 
particularly coagulase-negative staphylococci (CoNS) 
and propionibacteria, which had been considered as 
mere contaminants in the past. The real meaning of these 
microorganisms in the pathogenesis of human diseases 
has still to be clarified, and CoNS are not always identified 
at species level by many clinical microbiology laborato-
ries. However, as the pathogenic significance of CoNS 
increases, it may become important to learn more about 
the epidemiology and pathogenic potential of individual 
species. Their pathogenicity includes adhesion to human 
epithelial cells, production of biofilms, and invasion and 
lysis of human cells.12
Of the CoNS species, evidence is growing on the role 
Staphylococcus lugdunensis has as a PJI pathogen.13–15 Other 
CoNS, such as Staphylococcus warneri, Staphylococcus 
haemolyticus, Staphylococcus capitis, and Staphylococcus 
hominis, have been less frequently isolated and, consequently, 
less studied as causative agents of PJI, but can still have a 
role.16 These organisms are often thought to be skin con-
taminants and have been shown to contaminate up to 32% 
of prosthetic joints during surgery.17
The aim of this study was to document the presence of 
S. warneri, S. haemolyticus, S. capitis, and S. hominis in 
patients with hip and knee PJI, and compare this to S. aureus, 
specifically to determine if a difference is seen in terms of 
isolation rate and antimicrobial susceptibility, between strains 
isolated from patients who met the criteria for PJI diagnosis, 
compared to those who did not. 
Methods 
Patient characteristics
All patients presenting to our institute, a 300-bed reference 
center specializing in orthopedic surgery sited in Northern 
Italy, and undergoing revision surgery for suspected hip or 
knee PJI between January 2014 to December 2015 were con-
sidered eligible for the study. Since our hospital is one of the 
leading hospitals for prosthetic joint surgery at national level, 
the population served includes patients from all over Italy. 
All patients signed an informed consent to participate in 
the study which had previously received the approval of the 
Galeazzi Institute Review Board (composed of ten members 
including medical doctors and basic scientists). 
For each patient, erythrocyte sedimentation rate (ESR, 
mm/hr, laboratory range <20 mm/hr for females, <24 mm/
hr for males) and C-reactive protein (CRP: laboratory range 
0–5 mg/L) were measured on hospital admission. 
Diagnosis of infections was based on criteria estab-
lished by the International Consensus Meeting (ICM) held 
in Philadelphia in 2013.5,6 We have chosen to use these 
criteria to define the presence of a PJI as this takes into 
account previously defined criteria,3,4 and is the defini-
tion routinely used at our institute. The ICM criteria are 
dependent upon a combination of clinical examination, 
hematological, and microbiological results. However, 
despite the accuracy of these criteria, patients who did 
not meet the entire criterion were treated as such if we 
had a high index of suspicion of infection. Therefore, for 
the purposes of this study, we retrospectively divided our 
patient cohort by those meeting the criteria (Group A) and 
those who did not (Group B).
Sample collection
Four to six samples, or more, from the periprosthetic tissue 
as well as the implant (if removed) were collected from 
each patient of both groups during surgery prior to starting 
systemic antibiotics, unless the patient was systemically 
compromised. Postoperatively, for antibiotic prophylaxis, 
cefazolin (a first-generation cephalosporin antibiotic) was 
continued for 7 days or less, until culture results were known.
Samples were treated with dithiothreitol (DTT) in a 
closed-loop system for collection, transport, and treatment 
of samples within 1 hr from their arrival at the laboratory.17,18 
DTT has been shown to chemically detach bacteria from 
biofilm formed on the prosthetic implants and peripros-
thetic tissues, significantly increasing the rates of pathogen 
isolation.2,7,8
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Samples were then plated on agar plates and inoculated 
in broth for aerobic and anaerobic cultures. Chocolate agar 
and MacConkey agar were incubated for 24 hrs in presence 
and absence of 10% CO
2
, respectively. Mannitol salt agar 
and Sabouraud agar were incubated aerobically for 48 hrs. 
Finally, broths (Brain Heart Infusion and thioglycollate) were 
maintained for 15 days with daily visual inspection for bacte-
rial growth; in case of turbidity and at the end of incubation, 
an aliquot (10 µL) of broths was plated on blood agar and 
Schaedler agar (only thioglycollate). Microbial identifica-
tion and antibiotic susceptibility tests were carried out on a 
VITEK®2 Compact (bioMérieux, Marcy L’Etoile, France). 
Biochemical identification was confirmed by pyrosequenc-
ing analysis carried out on a PSQ96RA (Diatech, Jesi, Italy), 
as previously reported.19 Antibiotic panel for staphylococci 
(Card AST 632, bioMerieux) included 14 antibiotics: fusidic 
acid, clindamycin, daptomycin, erythromycin, gentamicin, 
levofloxacin, linezolid, oxacillin, rifampicin, teicoplanin, 
tetracycline, tigecycline, trimethoprim/sulfamethoxazole, 
and vancomycin, yielding MIC values and classifying the 
effectiveness as susceptible, intermediate, and resistant.20 
Statistical analysis
Statistical analysis was performed using two-tailed Fish-
er’s exact test when analyzing two groups directly, and 
 Chi-squared test with 3 or 4 degrees of freedom to compare 
all four pathogen groups. The antibiotic sensitivities were 
grouped as sensitive or not (including intermediate and 
resistant). In addition, Student’s t-test was used to compare 
bivariate data of means. A p-value of <0.05 was deemed to 
be statistically significant.
Results
Over the 24-month period, we obtained tissue samples 
from 580 patients. S. haemolyticus, S. capitis, S. hominis, 
and S. warneri were isolated from 66 patients (11.4%), 
and included 32 (48.5%) males, and 34 (51.5%) females 
(Table 1). S. aureus was isolated from 43 patients (7.4%), 
including 20 (46.5%) males and 23 (53.5%) females. The 
mean age of the cohort was 66.7 years (SD 13.7 years) 
(Table 2). No patient died in the study period and during the 
follow-up. Pyrosequencing confirmed biochemical identifica-
tion at species level of all CoNS performed by Vitek system. 
In four patients, S. aureus was isolated with S. epidermidis, 
and in one with Proteus mirabilis and Enterococcus faecalis. 
Furthermore, S. hominis was isolated with S. epidermidis in 
one patient, and with Propionibacterium acnes in another. 
S. capitis was also isolated with P. acnes once. 
Patient cohorts
Patients fulfilling criteria for PJI diagnosis (Group A)
Fifty patients with CoNS pathogens fulfilled the ICM criteria 
for PJI diagnosis (74.2%): 27 females (54%) and 23 males 
(46.0%), with a mean age of 65.5 years. Hip and knee PJI 
was diagnosed in 26 and 24 patients, respectively. Their mean 
preoperative ESR and CRP values were 34.5 mm/hr and 18.8 
mg/L. The most common CoNS species identified was S. 
capitis (Table 1). No differences were observed in isolation 
rate of CoNS between Group A and Group B (Table 1).
Thirty-nine patients with S. aureus also fulfilled the ICM 
criteria (90.7%): 20 females (51.3%) and 19 males (48.7%), 
with a mean age of 65.7 years (SD 13.9 years, range: 30–85 
years). Twenty-four (61.5%) had an infected hip and 15 
(38.5%) a knee PJI. Mean ESR was 58.6 mm/hr (SD 25 
mm/hr) and mean CRP was 52.4 mg/L (SD 51.5 mg/L). The 
mean ESR was statistically significantly higher for patients 
with S. aureus (p=0.002) than for patients with CoNS as well 
as number of patients with ESR >30 mm/hr (p=0.016) and 
CRP >10 mg/L (p<0.001) (Table 2). Frequency of isolation 
of S. aureus from Group A was significantly higher than from 
Group B (p=0.04; Table 1). 
Although follow-up was limited to only 2 years, two 
patients experienced a recurrence of the infection (one with 
S. capitis and one with S. hominis), while another was re-
admitted to hospital for infection of the revised prosthesis 
due to S. aureus 33 months after prosthesis revision. In three 
patients with S. aureus infections, the same microorgan-
ism was isolated later from the spacer during second stage 
revision surgery, while another was re-admitted to hospital 
for wound infection due to Klebsiella pneumoniae and Aci-
netobacter baumannii, both resistant to carbapenems and 
carbapenemase producers acquired during rehabilitation in 
another hospital. 
Patients not fulfilling ICM criteria (Group B)
S. warneri, S. hominis, S. capitis, and S. haemolyticus were 
isolated from 16 patients (25.8%) who did not fulfill the ICM 
Table 1 Pathogens isolated in each patient cohort
Group A Group B
n % n %
Staphylococcus capitis 19 21.3 6 30
Staphylococcus hominis 14 15.7 6 30
Staphylococcus warneri 11 12.4 3 15
Staphylococcus haemolyticus 6 6.7 1 5.0
Staphylococcus aureus 39 43.8 4 20
Total 89 100 20 100
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criteria for PJI: seven females and nine males, with a mean age 
of 61.19 years. Nine hip and seven knee PJI were included. 
Preoperative mean ESR and CRP were 24.5 mm/hr and 
3.07 mg/L. S. capitis and S. hominis were the most common 
CoNS isolated from these patients (Table 1).
S. aureus was isolated from only four patients not fulfilling 
the ICM criteria (Table 1): three females and one male with a 
mean age of 55.5 years (SD 17.8 years). One knee and three 
hip implants were affected. The mean ESR was 12.7 (SD 11.9 
mm/hr) and CRP was 2.18 (SD 1.45 mg/L). No statistically 
significant differences were seen comparing patients with S. 
aureus to patients with CoNS in the Group B cohort (Table 2). 
None of the patients of this group reported complications 
in the follow-up after revision surgery. All the strains isolated 
from this group were classified as contaminants. 
CoNS patient cohorts in Group A and Group B
No statistically significant difference was found between 
Group A and Group B CoNS patient cohorts in terms of 
their age, gender, and joint involvement. CRP was sig-
nificantly higher in patients of Group A compared to Group 
B (p=0.011), while no differences between groups were 
observed for ESR (Table 2).
Antibiotic susceptibility 
Antimicrobial susceptibility testing was performed for all 
isolates of both groups.
Patients fulfilling ICM criteria (Group A)
Table 3 demonstrates the antibiotic susceptibilities of the 
isolates of patients fulfilling the ICM criteria. The analysis 
of all the pathogens combined demonstrated a statistically 
significant difference among CoNS species. Resistance to 
levofloxacin, erythromycin, gentamicin, trimethoprim/sulfa-
methoxazole, and rifampicin was significantly more frequent 
in S. haemolyticus than in the other species (p<0.01 for levo-
floxacin, erythromycin, gentamicin, rifampicin, and p=0.03 
for trimethoprim/sulfamethoxazole), as well as resistance 
to erythromycin and gentamicin in S. hominis (p<0.001). 
Methicillin resistance did not significantly differ among the 
tested CoNS, even though it was more frequently observed 
in S. haemolyticus (p=0.055). Frequency of multidrug-
resistant (MDR) isolates, defined as resistance to at least 
three classes of antimicrobials significantly varied among 
CoNS (p=0.003), being more frequent in S. hominis (6/14 
isolates) and S. haemolyticus (3/6 isolates) than in S. capitis 
(1/19 isolates) and S. warneri (0/11). 
In comparison to S. aureus, CoNS were significantly more 
resistant to daptomycin and gentamicin (p=0.012) and more 
susceptible to rifampicin (p=0.03), while no significant dif-
ferences were observed in methicillin resistance (p=0.144) 
and in isolation rate of MDR staphylococci (10/50 CoNS vs 
15/39 S. aureus, p=0.062). 
Patients not fulfilling ICM criteria (Group B)
Isolates of patients not meeting the ICM criteria for PJI 
(Group B) are reported in Table 4. Among all the patho-
gens, the only significant differences between the antibiotic 
sensitivities were the rate of resistance of S. aureus against 
clindamycin (p=0.017) and that of S. capitis to erythromy-
cin (p=0.031). When comparing the statistical differences 
between S. aureus to the grouped CoNS, S. aureus was 
Table 2 Characteristics of patients of Group A and Group B
Characteristics Group A Group B p-values
Staphylococcus 
aureus (n=39)
CoNS
(n=50)
S. aureus  
(n=4)
CoNS  
(n=16)
S. aureus vs CoNS Group A vs  
Group B
n n n n Group A Group B CoNS
Gender Male
Female
20
19
23
27
1
3
9
7
0.150 0.248 0.176
Age (years) Mean (SD)
Range
65.7 (13.9)
30–85
65.0 (12.3)
29–84
55.5 (17.8)
31–71
61.3 (16.3)
19–87
0.810 0.557 0.327
Joint Hip
Knee
24
15
26
23
3
1
9
8
0.126 0.331 0.221
ESR (mm/hr) Mean (SD)
>30 mm/hr
Range
58.6 (25)
28
5–100
34.5 (24.5)
20
7–99
24.5 (/17.8)
0
3–26
24.5 (17.8)
4
5–55
0.002
0.016
0.266
0.484
0.209
0.202
CRP (mg/L) Mean (SD)
>10 mg/L
Range
52.4 (51.5)
34
3.2–255
28.3 (3.65)
26
0.5–485
2.18 (1.45)
0
0.3–3.5
3.07 (2.7)
0
0.8–9.9
0.087
<0.001
0.536
1.000
0.174
<0.011
Abbreviations: CoNS, coagulase-negative staphylococci; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein.
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relatively more resistant to clindamycin (p=0.002) and eryth-
romycin (p<0.001) than CoNS. Frequency of MDR isolates 
was significantly different among CoNS (p=0.003), reflecting 
what was observed for CoNS isolated from patients fulfilling 
ICM criteria. All S. hominis and S. haemolyticus isolates, but 
only one out of six S. capitis and 0 of three S. warneri were 
classified as MDR. Of the four S. aureus isolated in these 
patients, two were MDR. No differences were seen when 
MDR isolation rate of grouped CoNS was compared to that 
of S. aureus (p=1).
CoNS patient cohorts in Group A and Group B
Comparing the sensitivities of the CoNS isolated from 
patients fulfilling and not fulfilling the ICM criteria (Table 5), 
the only statistically significant difference between the two 
groups was levofloxacin susceptibility (p=0.009). Interest-
ingly, methicillin resistance in Group B was about half of 
that observed in Group A. Although notable, this difference 
failed to reach statistical significance (p=0.052). In contrast, 
MDR isolates were more frequently seen in CoNS of group 
B than in Group A (p=0.027). 
Table 3 Susceptibility of staphylococci isolated from patients fulfilling PJI criteria (group A)
Antibiotic Staphylococcus 
capitis
Staphylococcus 
hominis
Staphylococcus 
warneri
Staphylococcus 
haemolyticus
Staphylococcus 
aureus
S I R S I R S I R S I R S I R
Fusidic acid 16 0 3 10 0 4 11 0 0 4 0 2 37 0 2
Clindamycin 16 0 3 7 0 7 11 0 0 3 0 3 29 0 10
Daptomycin 15 0 4 14 0 0 10 0 1 6 0 0 39 0 0
Erythromycin 14 0 5 2 0 12 9 0 2 0 0 6 24 1 14
Gentamicin 18 0 1 5 0 9 8 0 3 1 0 5 33 0 6
Levofloxacin 17 0 2 10 0 4 11 0 0 1 0 5 23 0 16
Linezolid 19 0 0 14 0 0 11 0 0 6 0 0 39 0 0
Oxacillin 11 0 8 6 0 8 9 0 2 1 0 5 27 0 12
Rifampicin 19 0 0 14 0 0 10 0 1 2 0 4 27 1 11
Teicoplanin 19 0 0 14 0 0 11 0 0 6 0 0 38 0 1
Tetracycline 18 0 0 6 2 6 8 1 2 1 2 3 29 1 9
Tigecycline 19 0 0 14 0 0 11 0 0 6 0 0 39 0 0
Trimethoprim/sulfamethoxazole 18 0 1 12 2 0 11 0 0 3 0 3 37 0 2
Vancomycin 19 0 0 14 0 0 11 0 0 6 0 0 39 0 0
Abbreviations: PJI, prosthetic joint infection; S, susceptible; I, intermediate; R, resistant.
Table 4 Susceptibility of staphylococci isolated from patients not fulfilling PJI criteria (group B)
Antibiotic Staphylococcus  
capitis
Staphylococcus  
hominis
Staphylococcus  
warneri
Staphylococcus 
haemolyticus
Staphylococcus  
aureus
S I R S I R S I R S I R S I R
Fusidic acid 5 0 1 4 0 2 3 0 0 0 0 1 3 0 1
Clindamycin 6 0 0 5 0 1 3 0 0 1 0 0 1 0 3
Daptomycin 6 0 0 6 0 0 3 0 0 1 0 0 4 0 0
Erythromycin 6 0 0 4 0 2 2 0 1 0 0 1 1 0 3
Gentamicin 6 0 0 4 0 2 2 0 1 1 0 0 3 0 1
Levofloxacin 6 0 0 6 0 0 3 0 0 1 0 0 2 0 2
Linezolid 6 0 0 6 0 0 3 0 0 1 0 0 4 0 0
Oxacillin 5 0 1 5 0 1 3 0 0 0 0 1 2 0 2
Rifampicin 6 0 0 6 0 0 3 0 0 1 0 0 4 0 0
Teicoplanin 6 0 0 6 0 0 3 0 0 1 0 0 4 0 0
Tetracycline 4 2 0 4 2 0 2 1 0 0 0 1 3 0 1
Tigecycline 6 0 0 6 0 0 3 0 0 1 0 0 4 0 0
Trimethoprim/sulfamethoxazole 6 0 0 6 0 0 3 0 0 1 0 0 4 0 0
Vancomycin 6 0 0 6 0 0 3 0 0 1 0 0 4 0 0
Abbreviations: PJI, prosthetic joint infection; S, susceptible; I, intermediate; R, resistant.
Infection and Drug Resistance 2018:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
544
De Vecchi et al
Discussion
Staphylococci are recognized as the most frequent cause of 
PJI,4 with a prevalence of S. epidermidis and other CoNS over 
S. aureus. Unfortunately, in the reported literature, CoNS are 
not identified at species level but are often clustered together 
and reported as CoNS, apart from S. epidermidis and, more 
recently, S. lugdunensis. To our knowledge, minimal data 
have been published on the sensitivity of these individual 
CoNS and on comparisons between the antimicrobial sus-
ceptibility rates of CoNS and S. aureus isolated from bone 
and joint infections.21–25 
We have documented the current prevalence of these 
organisms in our patient cohort of 580 patients over a 2-year 
period (January 2014 to December 2015). This is a large 
patient cohort as our institute is a tertiary center for bone and 
joint infection, covering a large geographical area in Italy. The 
main pathogen isolated was S. aureus, but considered together, 
S. warneri, S. capitis, S. hominis, and S.  haemolyticus were 
found in a larger proportion of patients. No acute hematog-
enous infections were observed among our CoNS patients, 
thus suggesting that the pathogen may infect the implant 
perioperatively, as recently proposed by other authors regard-
ing S. capitis.22 Indeed, CoNS are known to be less aggressive 
and therefore patients may present low-grade infections and 
some of the ICM criteria may not be met routinely, despite the 
presence of PJI.12 Some differences in antimicrobial resistance 
were observed among CoNS, i.e., MDR isolates were more 
frequent in S. hominis and S.  haemolyticus than in S. capitis 
and S. warneri. Interestingly, although p-value did not reach 
statistical significance, the rate of methicillin resistance in S. 
haemolyticus was higher than that observed for S. hominis, S. 
warneri, and S. capitis, even though the low number of isolates 
does not allow for any conclusion to be drawn. 
Methicillin resistance has been shown to be more com-
mon among S. epidermidis and S. haemolyticus isolates than 
among S. aureus.26,27 Moreover, they may act as a reservoir 
of staphylococcal cassette chromosome (SCC) elements for 
S. aureus, including SCC harboring the MR gene mec (SCC-
mec) and the SCC-like arginine catabolic mobile element,28,29 
which favors staphylococcal colonization of the skin. 
Resistance to rifampicin was more frequently observed 
in S. aureus than in CoNS. Rifampicin is considered one of 
the antibiotics of choice for treatment of bone and joint infec-
tions, due to its ability to penetrate staphylococcal biofilms 
and to maintain its activity during chronic and active stage 
of infection.30,31 However, its use has been associated with 
the rapid emergence of resistant mutants, and therefore it 
is usually administered in combination with other agents.31 
In this study, the observed resistance rate to rifampicin in 
S. aureus does not greatly differ from that reported for other 
Italian isolates,32 but is higher than other studies, despite 
similar susceptibility of CoNS.23–25 In contrast, none of the 
staphylococci isolated from patients not fulfilling criteria for 
PJI was resistant to rifampicin. The high rate of resistance to 
rifampicin deserves further studies and some concerns arise 
regarding its use for treatment of PJIs, also considering that 
resistance to combination of rifampicin with other antibiotics, 
such as fluoroquinolones, is rising.24 
Table 5 Comparison of CoNS in Group A and B
Antibiotic Group A Group B p- value
Susceptible Not susceptible Susceptible Not susceptible
N % N % N % N %
Fusidic acid 41 82 9 18 12 75 4 25 0.540
Clindamycin 37 74 13 26 15 94 1 6 0.093
Daptomycin 45 90 5 10 16 100 0 0 0.086
Erythromycin 25 50 25 50 12 75 4 25 0.079
Gentamicin 32 64 18 36 13 81 3 19 0.197
Levofloxacin 39 78 11 22 16 100 0 0 0.009
Linezolid 50 100 0 0 16 100 0 0 1.000
Oxacillin 27 54 23 46 13 81 3 19 0.052
Rifampicin 45 90 5 10 16 100 0 0 0.086
Teicoplanin 50 100 0 0 16 100 0 0 1.000
Tetracycline 33 66 17 34 10 63 6 38 0.798
Tigecycline 50 100 0 0 16 100 0 0 1.000
Trimethoprim/ sulfamethoxazole 44 88 6 12 16 100 0 0 0.059
Vancomycin 50 100 0 0 16 100 0 0 1.000
Abbreviation: CoNS, coagulase negative staphylococci.
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Similarly, resistance to levofloxacin was more frequent in 
S. haemolyticus and S. aureus than in the comparators, and was 
also observed in S. aureus isolated from patients not fulfilling 
PJI criteria, but not in CoNS isolated from the same group of 
patients. Since 18 of 25 levofloxacin-resistant staphylococci 
were also methicillin resistant, it may be hypothesized that 
resistance to this fluoroquinolone could be associated with 
methicillin resistance, as suggested by others.33,34 Considering 
that in Italy fluoroquinolones are widely used, it may be hypoth-
esized that their use could have driven methicillin resistance 
development. However, because we have no data on previous 
antimicrobial therapy, this hypothesis cannot be confirmed. 
On the whole, these results highlight the importance of 
choosing the correct drug prophylaxis taking into consider-
ation the expected pattern of isolates following hip and knee 
PJI. Use of cefazolin in prophylaxis might be questioned 
considering the rate of methicillin resistance we observed. 
The common dominators with 100% sensitivity to all organ-
isms were linezolid, tigecycline, and vancomycin. 
However, vancomycin given prophylactically might 
increase the risk of infection due to the development of 
vancomycin resistant mutants, and Hawn et al. recommended 
combining it with a second agent, such as levofloxacin, to 
further reduce this risk.35,36 On the other hand, linezolid and 
tigecycline are considered second-line antimicrobials and 
their use in prophylaxis is not advisable. A new regimen 
should be evaluated by considering local epidemiology and 
ability of antibiotics to “select” resistance mutants, and other 
factors not associated with antimicrobial resistance patterns 
but with pharmacokinetic and pharmacodynamic properties 
and with patients’ characteristics.
Limitations of this study include that the results cannot 
be generalized as they are specific to our patient cohort. The 
results of this study do not reflect the surgical interventions 
undertaken by the responsible operating surgeon, as many 
factors should be taken into consideration in addition to the 
microbiological results, such as patient co-morbidities and 
soft tissue quality. A potential limit of this study could be 
the methods used to identify CoNS, as Vitek2 has shown 
some limitations in correctly identifying CoNS at species 
level compared to other more novel methods such as mass 
spectrometry.37,38 Therefore, we decided to confirm biochemi-
cal identification of CoNS with pyrosequencing analysis that 
confirmed results obtained with Vitek2 for all CoNS isolates.
Conclusion
CoNS other than S. epidermidis are frequently isolated from 
PJIs, but their role in the pathogenesis of the infection needs 
to be assessed for each patient. Our data have shown some 
differences in the antimicrobial susceptibility of the species of 
CoNS, highlighting the importance of species identification. 
Moreover, some differences in antimicrobial susceptibility 
exist between isolates from patients fulfilling PJI criteria and 
those not, although this cannot be considered a valid criterion 
to discriminate pathogens from contaminants. Finally, S. hae-
molyticus seems to emerge as a responsible pathogen of PJIs, 
and its role needs to be further elucidated, also considering 
its pattern of resistance. 
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